PRAGUE, Sept. 16, 2022 /PRNewswire/ — Between 7th and 9th September, the fourth ORBIS School was held in Prague. The occasion was co-hosted by Zentiva in shut collaboration with the German firm Physiolution and the University of Chemistry and Technology in Prague. Many varied lectures and workshops have been held throughout these three days and the members had a fantastic alternative to share their experiences and information based mostly on their very own analysis. Part of this system was a go to to Zentiva’s R&D division in its Prague website.
ORBIS (Open Research Biopharmaceutical Internships Support) is an international venture which is part of the EU program HORIZON 2020, centered on analysis and growth. ORBIS is a platform that unites universities, analysis institutes, and pharmaceutical corporations from a number of European international locations.
SUPPORTING AN INTERNATIONAL NETWORK TO ENHANCE RESEARCH AND DEVELOPMENT
Participants from Ireland, France, Finland, Germany, Poland and Ukraine got here to Prague for the ORBIS School. Lectures and workshops on the University of Chemistry and Technology and the Czech Technical University have been centered on biopharmaceutical ideas and novel methods or fashionable bioanalytical strategies. The purpose of the ORBIS venture is to strengthen the connection between tutorial and business fields, trade skilled information and create international partnerships throughout Europe, which might transfer pharmaceutical analysis forward. “Innovations are a crucial part of what we do. At Zentiva, almost 200 employees work in the R&D department. We support young talents and work on strengthening the academia-pharma industry cooperation. Joining the ORBIS project was an ideal opportunity to develop this type of cooperation on an international level. We believe that this kind of partnership is the key to success,” says Pavel Šebek, Development Director of Zentiva. “Meeting other experts with different backgrounds is very enriching. It is always interesting to hear about the experience of others and discover new original approaches to R&D. These events are always a great motivation,” says Nikita Marinko, a younger and gifted scientist from Zentiva who took half at this yr’s ORBIS School and was a part of the organizational staff that took care of all of the members.
Out of all 4 ORBIS faculties which have been held to date, two of them – the second and this one (the fourth one) – have been co-organized by Zentiva. In September 2019, in collaboration with the University of Helsinki, Zentiva organized the varsity overlaying the design of pharmaceutical dosage varieties and the manufacturing processes, whereas novel bio-relevant analytical approaches used in the characterization of dosage varieties have been coated this September in Prague. Both faculties have been notably based mostly on tutorial findings mixed with real-life examples, such utilized scientific approaches being appreciated by all members.
The excessive variety of attendees confirmed the power of the ORBIS scientific community and focus on modern approaches to satisfy at the moment unmet affected person wants.
About ORBIS – Open Research Biopharmaceutical Internships Support (Maria Skłodowska-Curie Actions of Horizon 2020 Framework Programme, H2020-MSCA-RISE-2017)
The overarching goal of ORBIS is to kind an international and inter-sectoral tutorial and industrial community. The motion is aimed toward bettering the preclinical pathway of drugs growth concentrating on processes and applied sciences. The purpose is to combine multidisciplinary analysis by involving the academia and the business from EU (Poland, Ireland, Finland, Germany, and the Czech Republic), EU related international locations (Ukraine) and US. The coordinator of the venture is Prof. Janina Lulek from Poznan University of Medical Sciences (Poland). Find out extra at www.orbisproject.eu.
About Zentiva
Zentiva is a producer of high-quality reasonably priced medicines serving sufferers in Europe and past. With a devoted staff of greater than 4,700 individuals and a community of manufacturing websites – together with flagship websites in Prague, Bucharest, and Ankleshwar – Zentiva strives to be the champion of branded and generic medicines in Europe to raised help individuals’s every day healthcare wants. At Zentiva it’s our aspiration that healthcare must be a proper and never a privilege. More than ever, individuals want higher entry to high-quality reasonably priced medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to offer the on a regular basis options that all of us rely on. Visit us at www.zentiva.com.
Media contact:
Mounira Lemoui
Head of Communications
ZENTIVA GROUP, a.s.
U Kabelovny 529/16, Dolní Měcholupy, 102 00 Prague 10
Cell: (+420) 727 873 159 / E-mail: [email protected]
Photo – https://mma.prnewswire.com/media/1900560/Zentiva_ORBIS_2022.jpg
